Palvella Therapeutics, Inc. · NASDAQ:PVLA

Kaupinen Wes reported a 14.60% stake in Palvella Therapeutics, Inc. (Schedule 13D)

Event Dec 13, 2024 · Filed Dec 20, 2024

Kaupinen Wes reported a 14.60% stake in Palvella Therapeutics, Inc., 1,644,869 shares, with active intent on Dec 13, 2024. Filed Dec 20, 2024 (Schedule 13D).

Stake
14.60%
Shares
1,644,869
Intent
Active
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Kaupinen Wes14.60%1,644,869
Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 20196.90%781,409
Christine L. Kaupinen13.90%1,562,818
Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 20196.90%781,409
Michael Christopher6.90%781,409

Source

View original at SEC

Related